A peptide that is 99% pure by HPLC can still carry enough bacterial endotoxin to switch on a macrophage. Endotoxin is invisible to UV detection and mass spectrometry, survives lyophilization, and is active in cell culture at concentrations far below anything a chromatogram would register. Endotoxin LAL testing is the standard way to measure it. This guide explains the biochemistry behind the Limulus amebocyte lysate (LAL) assay, compares the main formats, and covers the interference and masking problems that make peptides a tricky sample type.
What endotoxin is and why peptides can carry it
Endotoxin is lipopolysaccharide (LPS) shed from the outer membrane of Gram-negative bacteria. Its lipid A anchor is responsible for most of its biological activity, and it is chemically robust: ordinary autoclaving does not inactivate it, and much of it passes through 0.22 um sterilizing filters.
Synthetic peptides are made chemically, not by fermentation, so they start with far less endotoxin exposure than recombinant proteins. It can still enter through purification water, buffers, HPLC systems, glassware and handling. Once present, it is difficult to remove from a finished product; published removal strategies include ion exchange, affinity adsorbents, ultrafiltration and two-phase extraction, each with limits that depend on the molecule being purified [6].
The Limulus cascade
The test grew out of a 1968 observation that blood cells of the horseshoe crab Limulus polyphemus contain a clottable protein that gels in the presence of endotoxin [1]. Later biochemical work mapped the underlying cascade of serine protease zymogens [2]:
- Factor C binds endotoxin and autoactivates.
- Activated factor C activates factor B.
- Activated factor B converts the proclotting enzyme to clotting enzyme.
- Clotting enzyme cleaves coagulogen into coagulin, which polymerizes into a gel.
A second branch starts at factor G, which is activated by (1,3)-beta-D-glucans rather than endotoxin and feeds into the same proclotting enzyme [2]. That branch is the root of glucan-related false positives, for example from cellulose-based filters or materials exposed to fungal contamination.
Comparing LAL assay formats
| Format | Readout | Typical use |
|---|---|---|
| Gel-clot | Firm gel after inverting the tube (yes/no at a labelled sensitivity) | Limit tests; simple, low equipment needs |
| Kinetic turbidimetric | Time to reach a turbidity threshold | Quantitative, wide range |
| Kinetic chromogenic | Time to release a coloured product from a synthetic substrate | Quantitative, sensitive, plate-reader friendly |
| Recombinant factor C (rFC) | Fluorescence from a substrate cleaved by activated factor C | Quantitative; no factor G pathway, no horseshoe crab blood |
Recombinant factor C assays were proposed as a replacement that keeps the specificity of the first enzyme in the cascade while removing both the glucan branch and the dependence on harvested crab blood [3]. Values in all formats are expressed in endotoxin units (EU), calibrated against a reference standard endotoxin, and for a solid material are usually reported as EU per mg. The compendial method is described in USP chapter <85>, Bacterial Endotoxins Test.
Why peptides are a difficult matrix
LAL is an enzymatic cascade, and anything that affects enzyme activity or LPS aggregation can bias the measurement. Peptide samples bring several such factors:
- pH. Trifluoroacetate and acetate salts of basic peptides give acidic solutions. The reaction mixture must sit within the pH range specified by the reagent maker, which may require dilution in a suitable endotoxin-free buffer.
- Charge and amphipathicity. Cationic, amphipathic sequences can associate with the negatively charged lipid A region of LPS, which can reduce the amount the cascade detects.
- Chelators and divalent cations. The cascade depends on divalent cations. Chelating agents in a buffer can suppress it.
- Surfactants and excipients. Formulation components can change the size and structure of LPS aggregates.
The last two points connect to endotoxin masking (abbreviated LER in the pharmaceutical literature), in which endotoxin spiked into certain formulations becomes progressively undetectable by LAL over time. A 2022 review attributes the effect largely to interactions between formulation components and LPS that disrupt its supramolecular aggregates, while noting that the mechanism is not fully resolved [5].
The practical safeguard is the positive product control: a known amount of endotoxin is spiked into the sample at the test dilution, and the assay is valid only if the measured spike falls within the acceptance window set by the method, commonly 50 to 200%. If it does not, the sample is diluted further (within the maximum valid dilution) or pretreated, and the test is repeated.
When endotoxin content matters in peptide research
For many chemical and biophysical experiments, endotoxin is irrelevant. It becomes critical in cell-based work, particularly with innate immune cells. A 2014 study measured endotoxin in commercially available recombinant proteins, most labelled below 1 EU, and then exposed human monocytes, dendritic cells and the THP-1 cell line to LPS at 0.002 to 2 ng/mL [4]. Primary CD1c+ dendritic cells were activated by LPS amounts equivalent to the contamination found in some of the proteins, a sensitivity the authors linked to high CD14 expression. They recommended screening reagents by LAL or reporter-cell assays before use with LPS-sensitive cells.
For any peptide used in cell-culture models, including TB-500, the same logic applies: if the experimental system contains macrophages, monocytes or endothelial cells, a low-level endotoxin signal could be misread as a peptide effect.
A useful habit is to convert a lot's EU/mg figure into the endotoxin load that actually reaches the well. A peptide carrying 1 EU/mg and tested at a final concentration of 10 ug/mL delivers 0.01 EU/mL to the culture; the same lot tested at 100 ug/mL delivers ten times more. Comparing that number with the LPS sensitivity of the cell type in use shows whether endotoxin is a plausible confounder, and it explains why a signal can appear only at the top of a concentration series.
Practical steps for the bench
- Use depyrogenated glassware (dry heat) or certified endotoxin-free plastics and water.
- Run an LPS-only positive control and a vehicle control in immune-cell assays.
- Where a peptide effect looks inflammatory, test whether it survives polymyxin B or a TLR4 antagonist, which block LPS signalling.
- Record the endotoxin value and method (gel-clot, kinetic or rFC) with the lot data. Endotoxin figures, when reported, sit on the certificate alongside purity and identity; see our guide to reading a certificate of analysis and the lot data on our lab reports page.
- Remember that research-grade material is not specified as a pyrogen-free product; see what research use only means.
Key takeaways
- Endotoxin is heat-stable Gram-negative LPS that UV and mass detection do not see.
- The LAL assay uses the horseshoe crab factor C, factor B, proclotting enzyme and coagulogen cascade; the factor G branch responds to glucans.
- Gel-clot, turbidimetric, chromogenic and recombinant factor C formats trade simplicity against quantitation.
- Peptide pH, charge and buffer components can interfere, so spiked positive product controls are essential.
- Endotoxin matters most in immune-cell assays, where very low LPS levels can activate cells.
This article summarizes published research for informational purposes. All Ascent Sciences products are for laboratory research use only and are not for human or animal consumption.
References
- Levin J, Bang FB. Clottable protein in Limulus; its localization and kinetics of its coagulation by endotoxin. Thromb Diath Haemorrh. 1968;19(1):186-197. PubMed
- Iwanaga S. Biochemical principle of Limulus test for detecting bacterial endotoxins. Proc Jpn Acad Ser B Phys Biol Sci. 2007;83(4):110-119. PubMed
- Ding JL, Ho B. A new era in pyrogen testing. Trends Biotechnol. 2001;19(8):277-281. PubMed
- Schwarz H, Schmittner M, Duschl A, et al. Residual endotoxin contaminations in recombinant proteins are sufficient to activate human CD1c+ dendritic cells. PLoS One. 2014;9(12):e113840. PubMed
- Gorman A, Golovanov AP. Lipopolysaccharide structure and the phenomenon of low endotoxin recovery. Eur J Pharm Biopharm. 2022;180:289-307. PubMed
- Magalhães PO, Lopes AM, Mazzola PG, et al. Methods of endotoxin removal from biological preparations: a review. J Pharm Pharm Sci. 2007;10(3):388-404. PubMed
Frequently asked questions
What does the LAL test detect?
The Limulus amebocyte lysate test detects bacterial endotoxin, the lipopolysaccharide from the outer membrane of Gram-negative bacteria. Endotoxin in the sample activates a protease cascade in horseshoe crab blood-cell lysate, producing a gel, turbidity or a coloured product.
Why would a synthetic peptide contain endotoxin?
Solid-phase synthesis does not use bacteria, but endotoxin can be introduced from water, buffers, chromatography equipment, glassware and handling. It is heat-stable and not removed by lyophilization or ordinary filtration.
What is recombinant factor C?
It is a recombinant form of the first enzyme in the Limulus cascade. Assays built on it detect endotoxin through factor C alone, which avoids the glucan-sensitive factor G pathway and does not require horseshoe crab blood.
When does endotoxin content matter in peptide research?
It matters most in cell-based assays involving immune cells such as monocytes, macrophages and dendritic cells, which respond to very low lipopolysaccharide levels and can produce readouts that are wrongly attributed to the peptide.
All Ascent Sciences products are for laboratory research use only and are not for human or animal consumption. This article summarizes published research and is not medical advice. See our Research Use Agreement.